No. | Compound | Ames | in vitro test | in vivo test | Exposure dataa | |||
---|---|---|---|---|---|---|---|---|
1 | A | TA100, TA98, TA1537 | – | MN/CHL | + | MN/rat | + | Concomitant TK |
2 | B | TA100, TA98, TA2637, WP2uvrA | – | MN/CHL | + | MN/rat | + | PK |
3 | C | TA100, TA98, TA2637, WP2uvrA | – | MN/CHL | + | MN/rat | + | Concomitant TK |
4 | D | TA100, TA98 | – | CA/CHL | + | MN/mouse | – | Concomitant TK |
5 | E | TA100, TA1535, TA98, TA1537, WP2uvrA | – | CA/CHL | + | MN/rat | – | TK |
6 | F | TA100, TA1535, TA98, TA1537, WP2uvrA | – | MN/CHL | + | MN/rat | – | Concomitant TK |
7 | G | TA100, TA98 | – | MN/CHL | + | MN/rat | – | Concomitant TK |
8 | H | TA100, TA98, TA1537 | – | MN/CHL | + | MN/rat | – | Concomitant TK |
9 | I | TA100, TA1535, TA98, TA1537, WP2uvrA | – | CA/CHL | + | MN/rat | – | TK |
10 | J | TA100, TA1535, TA98, TA1537, WP2uvrA | – | CA/CHL | + | CA/rat | – | Concomitant TK |
11 | K | TA100, TA98 | – | CA/CHL | + | MN/rat | – | Concomitant TK |
12 | L | TA100, TA98 | – | CA/CHL | + | MN/rat | – | Concomitant TK |
13 | M | TA100, TA1535, TA98, TA1537, WP2uvrA | – | MN/CHL | + | MN/rat | – | TK |
14 | N | TA100, TA1535, TA98, TA1537, WP2uvrA | – | MN/CHL | + | MN/rat | – | Concomitant TK |
15 | O | TA100, TA1535, TA98, TA1537, WP2uvrA | – | CA/CHL | + | MN/rat | – | Concomitant TK |
16 | P | TA100, TA1535, TA98, TA1537, WP2uvrA | – | MN/CHL | + | MN/rat | – | Concomitant TK |
17 | Q | TA100, TA1535, TA98, TA1537, WP2uvrA | MN/CHL | + | MN/rat | – | Concomitant TK | |
18 | R | TA100, TA98, TA1537 | – | MN/CHL | + | MN/rat | – | Concomitant TK |